Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2023 Update

Artificial Intelligence (AI) in Financial Services - Thematic Intelligence


Summary

This report provides a breakdown of the key challenges in the financial services industry, and how AI can help solve them. It includes an overview of the AI value chain, including leaders and challengers for each sub-segment. It offers a review of the leading adopters of AI in financial services, relevant specialist AI vendors for financial services, and leading cross-industry AI vendors. It also provides case studies showing AI use cases across the financial services industry. Market size and growth forecasts for AI are provided, along with analysis of alternative data including patent, company filing, and hiring activity.

The financial services sector has been experiencing significant digitalization in recent years. Artificial Intelligence (AI) has been a critical technology in this journey as it is used in both front and back-end operations. From customer engagement and loan provisioning to the automation of laborious back-end tasks, AI can help drive efficiency across financial institutions. Other applications of AI in financial services include predicting customer behavior, fraud detection, and risk management. AI is also being used to personalize banking by deploying chatbots on apps to handle customer queries. In the insurance sector, AI has provided a great opportunity for innovation due to less complex products and underwriting processes. Current non-life use cases span product development, risk assessment, and claims processing.

Scope
  • AI has been crucial to the increased digitalization of the financial services industry as it can be used on many different fronts. For example, generative AI can be used to develop virtual assistants that provide personalized customer support. Using large language models, these virtual assistants can analyze financial data to provide tailored recommendations aligned with customers’ financial goals and preferences.
  • According to GlobalData forecasts, the total AI market will be worth $908.7 billion in 2030, having grown at a compound annual growth rate of 35.2% from $81.3 billion in 2022.
Reasons to Buy
  • Understand AI and its current and future impact on the financial services industry.
  • Learn how the deployment of AI can help with the key challenges the financial services sector faces.
  • Identify the leading AI adopters and specialist AI vendors.


Anika Therapeutics Inc Company Overview
Anika Therapeutics Inc Company Snapshot
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Anika Therapeutics Inc – Pipeline Analysis Overview
Business Description
Anika Therapeutics Inc - Key Facts
Anika Therapeutics Inc - Major Products and Services
Anika Therapeutics Inc Pipeline Products by Development Stage
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status
Anika Therapeutics Inc Pipeline Products Overview
All-Suture Anchor
All-Suture Anchor Product Overview
Cingal
Cingal Product Overview
Cingal Clinical Trial
Drug Delivery System
Drug Delivery System Product Overview
HA Based Orthobiologic - ACL
HA Based Orthobiologic - ACL Product Overview
HA Based Orthobiologic - Ankle
HA Based Orthobiologic - Ankle Product Overview
HA Based Orthobiologic - Bicep Repair
HA Based Orthobiologic - Bicep Repair Product Overview
HA Based Orthobiologic - Capsule Repair
HA Based Orthobiologic - Capsule Repair Product Overview
HA Based Orthobiologic - CMC
HA Based Orthobiologic - CMC Product Overview
HA Based Orthobiologic - Enthesis Repair
HA Based Orthobiologic - Enthesis Repair Product Overview
HA Based Orthobiologic - Hand/Foot
HA Based Orthobiologic - Hand/Foot Product Overview
HA Based Orthobiologic - Labrum Repair
HA Based Orthobiologic - Labrum Repair Product Overview
HA Based Orthobiologic - Meniscus
HA Based Orthobiologic - Meniscus Product Overview
HA Based Orthobiologic - Superior Capsule Reconstruction
HA Based Orthobiologic - Superior Capsule Reconstruction Product Overview
HA Based Orthobiologic - Tendons/Ligaments
HA Based Orthobiologic - Tendons/Ligaments Product Overview
HA Based Orthobiologic - Wrist
HA Based Orthobiologic - Wrist Product Overview
Hemostatic Patch
Hemostatic Patch Product Overview
HYAFF - Rotator Cuff Repair
HYAFF - Rotator Cuff Repair Product Overview
HYAFF Barrier Film
HYAFF Barrier Film Product Overview
HYAFF Gel
HYAFF Gel Product Overview
Hyalobone
Hyalobone Product Overview
Hyalofast
Hyalofast Product Overview
Hyalofast Clinical Trial
Hyalograft C Autograft
Hyalograft C Autograft Product Overview
Hyaluronic Acid - Synovial Joints
Hyaluronic Acid - Synovial Joints Product Overview
Interference Screw
Interference Screw Product Overview
Knotless Biocomposite Suture Anchor
Knotless Biocomposite Suture Anchor Product Overview
Knotless PEEK Suture Anchor
Knotless PEEK Suture Anchor Product Overview
MONOVISC - Hip
MONOVISC - Hip Product Overview
ORTHOVISC-T
ORTHOVISC-T Product Overview
Resorbable Suture Anchor
Resorbable Suture Anchor Product Overview
Sodium Hyaluronate - Osteoarthritis
Sodium Hyaluronate - Osteoarthritis Product Overview
Tissue Repair Suture
Tissue Repair Suture Product Overview
Upper Extremity Implant
Upper Extremity Implant Product Overview
Anika Therapeutics Inc - Key Competitors
Anika Therapeutics Inc - Key Employees
Anika Therapeutics Inc - Key Employee Biographies
Anika Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Anika Therapeutics Inc, Recent Developments
Jul 20, 2023: Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
Apr 19, 2023: Anika to issue first quarter 2023 financial results on Tuesday, may 9, 2023
Mar 06, 2023: Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
Feb 21, 2023: Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
Nov 08, 2022: Anika Reports Third Quarter Fiscal 2022 Financial Results
Oct 25, 2022: Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
Aug 03, 2022: Anika Reports Second Quarter Fiscal 2022 Financial Results
Jul 12, 2022: Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022
Jun 10, 2022: Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Anika Therapeutics Inc Pipeline Products by Equipment Type
Table 3: Anika Therapeutics Inc Pipeline Products by Indication
Table 4: Anika Therapeutics Inc, Key Facts
Table 5: Anika Therapeutics Inc, Major Products and Services
Table 6: Anika Therapeutics Inc Number of Pipeline Products by Development Stage
Table 7: Anika Therapeutics Inc Pipeline Products Summary by Development Stage
Table 8: Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status
Table 9: Anika Therapeutics Inc Ongoing Clinical Trials Summary
Table 10: All-Suture Anchor - Product Status
Table 11: All-Suture Anchor - Product Description
Table 12: Cingal - Product Status
Table 13: Cingal - Product Description
Table 14: Cingal - A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis (ECHO Study)
Table 15: Cingal - Effectiveness of Cingal for Improving Pain Scores and Function in Anterior Knee Pain
Table 16: Drug Delivery System - Product Status
Table 17: Drug Delivery System - Product Description
Table 18: HA Based Orthobiologic - ACL - Product Status
Table 19: HA Based Orthobiologic - ACL - Product Description
Table 20: HA Based Orthobiologic - Ankle - Product Status
Table 21: HA Based Orthobiologic - Ankle - Product Description
Table 22: HA Based Orthobiologic - Bicep Repair - Product Status
Table 23: HA Based Orthobiologic - Bicep Repair - Product Description
Table 24: HA Based Orthobiologic - Capsule Repair - Product Status
Table 25: HA Based Orthobiologic - Capsule Repair - Product Description
Table 26: HA Based Orthobiologic - CMC - Product Status
Table 27: HA Based Orthobiologic - CMC - Product Description
Table 28: HA Based Orthobiologic - Enthesis Repair - Product Status
Table 29: HA Based Orthobiologic - Enthesis Repair - Product Description
Table 30: HA Based Orthobiologic - Hand/Foot - Product Status
Table 31: HA Based Orthobiologic - Hand/Foot - Product Description
Table 32: HA Based Orthobiologic - Labrum Repair - Product Status
Table 33: HA Based Orthobiologic - Labrum Repair - Product Description
Table 34: HA Based Orthobiologic - Meniscus - Product Status
Table 35: HA Based Orthobiologic - Meniscus - Product Description
Table 36: HA Based Orthobiologic - Superior Capsule Reconstruction - Product Status
Table 37: HA Based Orthobiologic - Superior Capsule Reconstruction - Product Description
Table 38: HA Based Orthobiologic - Tendons/Ligaments - Product Status
Table 39: HA Based Orthobiologic - Tendons/Ligaments - Product Description
Table 40: HA Based Orthobiologic - Wrist - Product Status
Table 41: HA Based Orthobiologic - Wrist - Product Description
Table 42: Hemostatic Patch - Product Status
Table 43: Hemostatic Patch - Product Description
Table 44: HYAFF - Rotator Cuff Repair - Product Status
Table 45: HYAFF - Rotator Cuff Repair - Product Description
Table 46: HYAFF Barrier Film - Product Status
Table 47: HYAFF Barrier Film - Product Description
Table 48: HYAFF Gel - Product Status
Table 49: HYAFF Gel - Product Description
Table 50: Hyalobone - Product Status
Table 51: Hyalobone - Product Description
Table 52: Hyalofast - Product Status
Table 53: Hyalofast - Product Description
Table 54: Hyalofast - A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control
Table 55: Hyalofast - A Study on the Safety and Effectiveness of Improved Microfracture Techniques Using Temperature Sensitive Polymer Hydrogel for Femoral and Cartilage Defects– Prospective, Randomize, Single–center
Table 56: Hyalograft C Autograft - Product Status
Table 57: Hyalograft C Autograft - Product Description
Table 58: Hyaluronic Acid - Synovial Joints - Product Status
Table 59: Hyaluronic Acid - Synovial Joints - Product Description
Table 60: Interference Screw - Product Status
Table 61: Interference Screw - Product Description
Table 62: Knotless Biocomposite Suture Anchor - Product Status
Table 63: Knotless Biocomposite Suture Anchor - Product Description
Table 64: Knotless PEEK Suture Anchor - Product Status
Table 65: Knotless PEEK Suture Anchor - Product Description
Table 66: MONOVISC - Hip - Product Status
Table 67: MONOVISC - Hip - Product Description
Table 68: ORTHOVISC-T - Product Status
Table 69: ORTHOVISC-T - Product Description
Table 70: Resorbable Suture Anchor - Product Status
Table 71: Resorbable Suture Anchor - Product Description
Table 72: Sodium Hyaluronate - Osteoarthritis - Product Status
Table 73: Sodium Hyaluronate - Osteoarthritis - Product Description
Table 74: Tissue Repair Suture - Product Status
Table 75: Tissue Repair Suture - Product Description
Table 76: Upper Extremity Implant - Product Status
Table 77: Upper Extremity Implant - Product Description
Table 78: Anika Therapeutics Inc, Key Employees
Table 79: Anika Therapeutics Inc, Key Employee Biographies
Table 80: Anika Therapeutics Inc, Subsidiaries
Table 81: Glossary
List of Figures
Figure 1: Anika Therapeutics Inc Pipeline Products by Equipment Type
Figure 2: Anika Therapeutics Inc Pipeline Products by Development Stage
Figure 3: Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings